SCHEMBL22084134

SCHEMBL22084134

O=c1cc(-c2ccccc2Cl)oc2cc(OP(=O)(O)O)cc(O)c12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.70
▸ KMT2A Q03164 8/20 0.70
▸ HPGD P15428 7/20 0.70
▸ ALDH1A1 P00352 4/20 0.70
▸ GABRP O00591 3/20 0.70
▸ GABRD O14764 3/20 0.70
▸ GABRA1 P14867 3/20 0.70
▸ GABRB1 P18505 3/20 0.70
▸ GABRG2 P18507 3/20 0.70
▸ GABRB3 P28472 3/20 0.70
▸ GABRA5 P31644 3/20 0.70
▸ GABRA3 P34903 3/20 0.70
▸ GABRA2 P47869 3/20 0.70
▸ GABRB2 P47870 3/20 0.70
▸ GABRA4 P48169 3/20 0.70
▸ GABRE P78334 3/20 0.70
▸ GABRA6 Q16445 3/20 0.70
▸ GABRG1 Q8N1C3 3/20 0.70
▸ GABRG3 Q99928 3/20 0.70
▸ GABRQ Q9UN88 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370763 0.85 MEN1 (0.75) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL13259767 0.83 MEN1 (1.00) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL19469987 0.81 FLT3 (0.70) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL16977184 0.77 MAOB (0.79) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL19470002 0.76 CYP1B1 (0.71) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL26117399 0.73 CYP3A4 (0.76) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL29435855 0.73 CYP3A4 (0.76) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL3708991 0.71 MEN1 (1.00) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL974549 0.70 MAPT (0.76) MEN1KMT2AHPGDALDH1A1GABRP
SCHEMBL2905489 0.70 CYP1B1 (0.72) MEN1KMT2AHPGDALDH1A1GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117988-A1 CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER TOLERO PHARMACEUTICALS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback